Menu

• Ask a Health Expert about APLASIA
• Post Your Side Effect related to APLASIA
• APLASIA and FDA Warnings
• APLASIA in Patients Wiki
• Report APLASIA in Drug Side Effect Survey

APLASIA side effect

What is APLASIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Humira Side Effects Report #5654106-X
Physician from FRANCE reported HUMIRA problem on Feb 25, 2008. Female patient, weighting 136.7 lb, was diagnosed with spondylitis, crohn's disease, hypertension and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: aplasia, myelodysplastic syndrome, thrombocytopenia, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, INFLIXIMAB, MESALAMINE, LEVOFLOXACIN, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Ambisome Side Effects Report #5583329-3
AMBISOME problem was reported by a Health Professional from FRANCE on Dec 21, 2007. Female patient, weighting 127.9 lb, was diagnosed with histoplasmosis, hiv infection and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: aplasia, hepatic enzyme increased, immune reconstitution syndrome, pancytopenia, . AMBISOME dosage: unknown. During the same period patient was treated with TRUVADA, BACTRIM, NORVIR, REYATAZ, SPECIAFOLDINE, TRIFLUCAN. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5584543-3
Physician from FRANCE reported VINCRISTINE problem on Dec 19, 2007. Male patient, 17 years of age, was diagnosed with b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: aplasia, cholestasis, hepatosplenic candidiasis, immune reconstitution syndrome, no therapeutic response, . VINCRISTINE dosage: unknown. During the same period patient was treated with PREDNISONE, DOXORUBICIN, METHOTREXATE, CYTARABINE, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Sprycel Side Effects Report #5585773-7
SPRYCEL problem was reported by a Physician from FRANCE on Jan 07, 2008. Female patient, 65 years of age, weighting 189.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: aplasia, pleural effusion, . SPRYCEL dosage: RESTARTED WITH REDUCED DOSE OF 40MG/D ON 05OCT07 AND STOPPED ON 29OCT07. Patient recovered.


Humira Side Effects Report #5596091-5
Health Professional from FRANCE reported HUMIRA problem on Jan 08, 2008. Female patient, weighting 169.8 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: aplasia, balance disorder, cerebral infarction, cerebral venous thrombosis, coma, confusional state, depressed level of consciousness, headache, hemiplegia, . HUMIRA dosage: unknown. During the same period patient was treated with PREDNISONE, AZATHIOPRINE, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5597623-3
VINCRISTINE problem was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2008. Male patient, 17 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: aplasia, hepatosplenic candidiasis, immune reconstitution syndrome, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE, CYTARABINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Holoxan Side Effects Report #5599668-6
Consumer or non-health professional from UNITED STATES reported HOLOXAN problem on Jan 11, 2008. Male patient, child 11 years of age, was diagnosed with chondrosarcoma and was treated with HOLOXAN. After drug was administered, patient experienced the following problems/side effects: aplasia, apraxia, mucosal inflammation, multi-organ failure, walking disability, . HOLOXAN dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, UROMITEXAN. Patient died on 12/17/2007.

Cyclophosphamide Side Effects Report #5601811-7
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Female patient, 65 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: aplasia, atrial fibrillation, cardiac failure, cardiogenic shock, diabetes mellitus inadequate control, disorientation, dyspnoea at rest, left ventricular dysfunction, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL, TAXOTERE. Patient was hospitalized. Patient died on 10/02/2007.

Ammonul Side Effects Report #5603346-4
Physician from FRANCE reported AMMONUL problem on Jan 09, 2008. Female patient, 19 years of age, weighting 121.3 lb, was diagnosed with hyperammonaemia, prophylaxis and was treated with AMMONUL. After drug was administered, patient experienced the following problems/side effects: aplasia, coma, haemorrhage, sepsis, thrombocytopenia, . AMMONUL dosage: unknown. During the same period patient was treated with POSOCONAZOLE, NEXIUM, TIENAM, ORGARAN, LEVOCARNIL, ARGININE. Patient recovered.


Cgp Side Effects Report #5604015-7
CGP problem was reported by a Physician from FRANCE on Jan 16, 2008. Male patient, 34 years of age, weighting 121.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: aplasia, asthenia, bacterial infection, bladder catheterisation, chills, escherichia sepsis, febrile neutropenia, flank pain, haemodynamic instability, . CGP dosage: 400 MG, BID. During the same period patient was treated with HYPER, MOPRAL, TRANSIPEG, MYOLASTAN, VALACYCLOVIR, LARGACTIL, PRIMPERAN, SPASFON. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5615476-1
Consumer or non-health professional from FRANCE reported VINCRISTINE problem on Jan 25, 2008. Male patient, 17 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: aplasia, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, gamma-glutamyltransferase increased, hepatosplenic candidiasis, immune reconstitution syndrome, pyrexia, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE, CYTARABINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5533310-5
GEMTUZUMAB OZOGAMICIN problem was reported by a Physician from ITALY on Nov 22, 2007. Female patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: aplasia, sepsis, . GEMTUZUMAB OZOGAMICIN dosage: unknown. During the same period patient was treated with LEVOFLOXACIN, NEUPOGEN, IDARUBICIN, ETOPOSIDE, CYTARABINE, TRANEXAMIC ACID, HYDROCORTISON. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5549550-5
Health Professional from ITALY reported IMATINIB problem on Dec 03, 2007. Male patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: aplasia, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow necrosis, erythroblast count increased, hyperpyrexia, pain in extremity, . IMATINIB dosage: 600 MG/D. Patient recovered.

Gemtuzumab Side Effects Report #5557936-8
GEMTUZUMAB OZOGAMICIN problem was reported by a Physician from ITALY on Dec 11, 2007. Female patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: aplasia, sepsis, . GEMTUZUMAB OZOGAMICIN dosage: unknown. During the same period patient was treated with LEVOFLOXACIN, FILGRASTIM, IDARUBICIN, ETOPOSIDE, CYTARABINE, TRANEXAMIC ACID. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5565830-1
Physician from FRANCE reported VELCADE problem on Nov 27, 2007. Female patient, 56 years of age, weighting 103.6 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aplasia, dysphagia, hiatus hernia, oesophageal candidiasis, pancytopenia, peptic ulcer, . VELCADE dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, MESNA, GRANOCYTE, VALACYCLOVIR. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5575890-X
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from FRANCE on Dec 24, 2007. Male patient, 17 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: aplasia, hepatosplenic candidiasis, immune reconstitution syndrome, pyrexia, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with CISPLATIN, DOXORUBICIN, METHOTREXATE, ETOPOSIDE, VINCRISTINE SULPHATE, CYTARABINE, DEXAMETHASONE, PREDNISONE. Patient recovered.

Imatinib Side Effects Report #5526200-5
Physician from FRANCE reported IMATINIB problem on Nov 22, 2007. Female patient, 51 years of age, weighting 165.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: aplasia, candida sepsis, intubation, mechanical ventilation, neutropenia, respiratory failure, staphylococcal infection, . IMATINIB dosage: 400 MG, BID. During the same period patient was treated with TAZOCILLINE, HIPAZIN, PLITICAN, ZOPHREN, SOTALOL, BACTRIM. Patient recovered.

Irbesartan Side Effects Report #5527501-7
IRBESARTAN problem was reported by a Health Professional from FRANCE on Nov 26, 2007. Female patient, 83 years of age, was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: aplasia, pancytopenia, renal failure, . IRBESARTAN dosage: unknown. During the same period patient was treated with PROTELOS, DICYNONE, NOCTRAN, BROMAZEPAM, STRUCTUM, SEGLOR, TANAKAN, METEOXANE. Patient was hospitalized. Patient died on 07/08/2007.

Cyclophosphamide Side Effects Report #5472477-4
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Sept 20, 2007. Female patient, 78 years of age, was diagnosed with chronic lymphocytic leukaemia stage 4, antifungal prophylaxis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: aplasia, granulocytes maturation arrest, neutropenia, renal impairment, sepsis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARA, AMITRIPTYLINE. Patient recovered.


Taxol Side Effects Report #5475879-5
TAXOL problem was reported by a Health Professional from FRANCE on Oct 01, 2007. Female patient, child 2 years of age, was diagnosed with congenital teratoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: aplasia, mouth ulceration, pyrexia, . TAXOL dosage: unknown. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5479948-5
Health Professional from FRANCE reported RITUXIMAB problem on Oct 03, 2007. Female patient was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, escherichia sepsis, haematuria, . RITUXIMAB dosage: 700 MG/KG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5485363-0
CISPLATIN problem was reported by a Consumer or non-health professional from SWITZERLAND on Oct 01, 2007. Male patient, 28 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: aplasia, arthritis bacterial, cytomegalovirus infection, graft versus host disease, hypogammaglobulinaemia, malignant neoplasm progression, pneumonitis, renal failure acute, . CISPLATIN dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE, VINCRISTINE SULPHATE, CARMUSTINE, DOXORUBICIN, CICLOSPORIN, CYTARABINE. Patient recovered.

Cyclophosphamide Side Effects Report #5488745-6
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Oct 10, 2007. Male patient, 28 years of age, was diagnosed with diffuse large b-cell lymphoma, immunosuppression, prophylaxis against graft versus host disease and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: aplasia, cytomegalovirus test, graft versus host disease, hypogammaglobulinaemia, lymphopenia, pneumonitis, polyarthritis, renal failure acute, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE, METHOTREXATE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, METHYLPREDNISOLONE. Patient recovered.

Rituximab Side Effects Report #5488864-4
RITUXIMAB problem was reported by a Physician from FRANCE on Oct 10, 2007. Female patient was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, cardio-respiratory arrest, septic shock, tachycardia, . RITUXIMAB dosage: 750 MG, UNK. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, LENOGRASTIM, ZOFRAN, PRIMPERAN. Patient died on 08/16/2005.

Doxorubicin Side Effects Report #5492895-8
Consumer or non-health professional from SWITZERLAND reported DOXORUBICIN problem on Oct 03, 2007. Male patient, 28 years of age, was diagnosed with b-cell lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: aplasia, arthralgia, arthritis infective, b-cell lymphoma recurrent, bone pain, bronchopulmonary aspergillosis, cytomegalovirus infection, erythema, . DOXORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE, ETOPOSIDE, CISPLATIN, METHOTREXATE, CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5496768-6
ZEVALIN problem was reported by a Health Professional from FRANCE on Oct 11, 2007. Male patient, 57 years of age, was diagnosed with bone marrow conditioning regimen and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: aplasia, cholestasis, clostridial infection, culture stool positive, escherichia infection, febrile neutropenia, lung neoplasm, pancytopenia, respiratory syncytial virus infection, . ZEVALIN dosage: unknown. During the same period patient was treated with TAZOCILLINE, FORTUM, MABTHERA, ETOPOSIDE, CYTARABINE, BICNU, ALKERAN, KEPIVANCE. Patient was hospitalized. Patient recovered.

Cgp Side Effects Report #5501515-5
Physician from FRANCE reported CGP problem on Oct 25, 2007. Female patient, 51 years of age, weighting 165.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: aplasia, intubation, mechanical ventilation, neutropenia, respiratory failure, sepsis, . CGP dosage: 400 MG, BID. During the same period patient was treated with TAZOCILLINE, HIPAZIN, PLITICAN, ZOFRAN, SOTALOL. Patient recovered.

Bevacizumab Side Effects Report #5503221-X
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Oct 17, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, haemoglobin decreased, pyrexia, . BEVACIZUMAB dosage: 234 MG, Q3W. During the same period patient was treated with IRINOTECAN, CAPECITABINE, CLINOMEL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5444326-1
Health Professional from GERMANY reported CETUXIMAB problem on Aug 31, 2007. Female patient was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, infection, . CETUXIMAB dosage: 5 MG/ML. During the same period patient was treated with CISPLATIN, TOPOTECAN. Patient recovered.

Cetuximab Side Effects Report #5444327-3
CETUXIMAB problem was reported by a Health Professional from GERMANY on Aug 31, 2007. Female patient was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, infection, . CETUXIMAB dosage: 5 MG/ML. During the same period patient was treated with CISPLATIN, TOPOTECAN. Patient recovered.

Cetuximab Side Effects Report #5444465-5
Health Professional from GERMANY reported CETUXIMAB problem on Aug 31, 2007. Female patient was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, infection, . CETUXIMAB dosage: CETUXIMAB 5MG/ML. During the same period patient was treated with CISPLATIN, TOPOTECAN. Patient recovered.

Cetuximab Side Effects Report #5444866-5
CETUXIMAB problem was reported by a Health Professional from GERMANY on Aug 31, 2007. Female patient was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, infection, . CETUXIMAB dosage: FORM=5MG/ML. During the same period patient was treated with CISPLATIN, TOPOTECAN. Patient recovered.

Velcade Side Effects Report #5448211-0
Physician from GERMANY reported VELCADE problem on Aug 23, 2007. Female patient, 56 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aplasia, pneumonia, stem cell transplant, . VELCADE dosage: unknown. During the same period patient was treated with MELPHALAN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5450094-X
CETUXIMAB problem was reported by a Health Professional from GERMANY on Sept 04, 2007. Female patient, 70 years of age, was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, febrile neutropenia, infection, thrombocytopenia, . CETUXIMAB dosage: CETUXIMAB 5MG/ML. PREVIOUSLY 400 MG/M2 (1 IN 1 WEEK).. During the same period patient was treated with CISPLATIN, TOPOTECAN. Patient was hospitalized. Patient recovered.

Sprycel Side Effects Report #5455348-9
Physician from FRANCE reported SPRYCEL problem on Sept 13, 2007. Female patient, 65 years of age, was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: aplasia, pleural effusion, . SPRYCEL dosage: unknown. Patient recovered.

Taxol Side Effects Report #5465795-7
TAXOL problem was reported by a Health Professional from FRANCE on Sept 20, 2007. Female patient, child 2 years of age, was diagnosed with congenital teratoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: aplasia, mouth ulceration, pyrexia, . TAXOL dosage: unknown. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Tretinoin Side Effects Report #5415627-8
Physician from ITALY reported TRETINOIN problem on Aug 08, 2007. Male patient, weighting 158.7 lb, was diagnosed with acute promyelocytic leukaemia and was treated with TRETINOIN. After drug was administered, patient experienced the following problems/side effects: aplasia, . TRETINOIN dosage: unknown. During the same period patient was treated with MERCAPTOPURINE, METHOTREXATE, FOLIC ACID. Patient recovered.

Rituxan Side Effects Report #5418690-3
RITUXAN problem was reported by a Physician from FRANCE on Aug 10, 2007. Female patient, 59 years of age, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: aplasia, pyrexia, . RITUXAN dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, ENDOXAN, CORTANCYL. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5420771-5
Physician from FRANCE reported TEMODAL problem on Aug 09, 2007. Female patient, 67 years of age, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: aplasia, bone marrow failure, infection, pancytopenia, . TEMODAL dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ZOFRAN, BACTRIM DS. Patient died on 07/05/2007.

Gleevec Side Effects Report #5421991-6
GLEEVEC problem was reported by a Physician from BRAZIL on Aug 14, 2007. Male patient, 57 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: aplasia, blood albumin decreased, bronchopneumonia, haematocrit decreased, hepatosplenomegaly, platelet count decreased, pleural effusion, pyrexia, white blood cell count decreased, . GLEEVEC dosage: 400 MG/D. Patient was hospitalized. Patient recovered.

Bicnu Side Effects Report #5425049-1
Health Professional from FRANCE reported BICNU problem on Aug 22, 2007. Female patient, 34 years of age, was treated with BICNU. After drug was administered, patient experienced the following problems/side effects: aplasia, bone marrow failure, cor pulmonale acute, inflammation, multi-organ failure, pneumonitis, pseudomonas infection, . BICNU dosage: unknown. During the same period patient was treated with TEMODAL. Patient was hospitalized. Patient died on 04/18/2007.

Temodal Side Effects Report #5428851-5
TEMODAL problem was reported by a Physician from FRANCE on Aug 17, 2007. Female patient, 34 years of age, was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: aplasia, interstitial lung disease, multi-organ failure, pseudomonal sepsis, purpura, septic shock, thrombocytopenia, . TEMODAL dosage: unknown. During the same period patient was treated with BICNU. Patient died on 04/18/2007.

Temozolomide Side Effects Report #5441513-3
Pharmacist from FRANCE reported TEMOZOLOMIDE problem on Aug 24, 2007. Female patient, 70 years of age, was diagnosed with glioblastoma and was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: aplasia, haemorrhage, thrombocytopenic purpura, . TEMOZOLOMIDE dosage: unknown. During the same period patient was treated with FUNGIZONE, PARACETAMOL. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5379480-3
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on June 28, 2007. Female patient, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, pyrexia, . RITUXIMAB dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOZOL. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5384832-1
Physician from UNITED KINGDOM reported RITUXIMAB problem on July 05, 2007. Female patient, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, pyrexia, . RITUXIMAB dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOZOL. Patient was hospitalized. Patient recovered.

Temozolomide Side Effects Report #5392812-5
TEMOZOLOMIDE problem was reported by a Pharmacist from FRANCE on July 11, 2007. Female patient, 70 years of age, was diagnosed with glioblastoma and was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: aplasia, haemorrhage, purpura, thrombocytopenia, . TEMOZOLOMIDE dosage: unknown. During the same period patient was treated with FUNGIZONE, PARACETAMOL. Patient recovered.

Imatinib Side Effects Report #5394985-7
Health Professional from ITALY reported IMATINIB MESYLATE problem on July 12, 2007. Male patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: aplasia, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow necrosis, erythroblast count increased, hyperpyrexia, pain in extremity, . IMATINIB MESYLATE dosage: 600 MG/D. Patient recovered.

Rocephin Side Effects Report #5396761-8
ROCEPHIN problem was reported by a Physician from FRANCE on July 13, 2007. Female patient, 87 years of age, was diagnosed with pyelonephritis and was treated with ROCEPHIN. After drug was administered, patient experienced the following problems/side effects: aplasia, sigmoiditis, . ROCEPHIN dosage: unknown. During the same period patient was treated with TAZOCILLINE, AMIKLIN. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5379480-3
Physician from UNITED KINGDOM reported RITUXIMAB problem on June 28, 2007. Female patient, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, pyrexia, . RITUXIMAB dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOZOL. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5384832-1
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on July 05, 2007. Female patient, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, pyrexia, . RITUXIMAB dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOZOL. Patient was hospitalized. Patient recovered.

Temozolomide Side Effects Report #5392812-5
Pharmacist from FRANCE reported TEMOZOLOMIDE problem on July 11, 2007. Female patient, 70 years of age, was diagnosed with glioblastoma and was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: aplasia, haemorrhage, purpura, thrombocytopenia, . TEMOZOLOMIDE dosage: unknown. During the same period patient was treated with FUNGIZONE, PARACETAMOL. Patient recovered.